Detection of Clostridium difficile in 40 minutes*
Xpert® Carba-R
Detection and differentiation of KPC, NDM, VIM, IMP-1, and OXA-48 in 48 minutes
Diagnostics First
The Need
- The emergence and global spread of carbapenemase-producing organisms (CPO) is of great concern to health services worldwide
- These bacteria are often resistant to all beta-lactam antibiotics and frequently co-resistant to most other antibiotics, leaving very few treatment options
- Healthcare facilities need the ability to test high-risk patients and get an accurate result quickly during or prior to the admission process for better patient and bed management
- Traditional enriched culture methods are laborious, taking up to 72 hours for a result
- To address this infection control challenge, it is desirable to have a rapid, accurate, and easy to use on-demand PCR test
- A comprehensive test that detects and differentiates the most prevalent carbapenemases gene families (KPC, NDM, VIM, IMP-1 and OXA-48, now covering OXA-181 and OXA- 232) is important for a successful infection control program
The Solution
- Xpert Carba-R is an on-demand PCR test that detects and differentiates the most prevalent carbapenemases gene families (KPC, NDM, VIM, IMP-1 and OXA-48, now covering OXA-181 & OXA-232) in 48 minutes
- Xpert Carba-R provides rapid and accurate detection of CPO; giving you actionable information to help prevent outbreaks and help determine the best patient management pathway
- Enhance your infection control program with Xpert Carba-R by identifying patients that are colonized with CPO quickly
- Xpert Carba-R identifies the specific genes that code for carbapenemase production that common culture methods alone cannot provide. Even sophisticated culture methods would not reveal these results in a time frame that allows effective infection control interventions
- Xpert Carba-R delivers the best tool for surveillance, monitoring, and control of CPOs
The Impact
Xpert Carba-R is a critical tool:
Xpert Carba-R is a much-needed tool for rapid and accurate detection of patients colonized with multidrug resistant organisms to help prevent widespread outbreaks and determine the best infection prevention pathways. for rapid and accurate detection of patients colonized with multidrug resistant organisms to help prevent outbreaks and determine the best infection prevention pathways.
- For active screening of patients transferred across borders and between healthcare facilities
- For active screening of high risk patients: from long-term care facilities, in transplant units, surgery and ICUs Impact on Patient Pathway
Ordering Info
Xpert® Carba-R
Number of Tests: 10
Catalog #: GXCARBAR-CE-10Xpert® Carba-R
Number of Swabs: 50
Catalog #: 900-0370
